Evidence map›Paper›PMID 33667550›Full record

ArticleThe Journal of biological chemistry

Modifying the resolving cysteine affects the structure and hydrogen peroxide reactivity of peroxiredoxin 2.

Alexander V Peskin, Flavia C Meotti, Kelsey M Kean, Christoph Göbl, Albert Souza Peixoto, Paul E Pace, Christopher R Horne, Sarah G Heath, Jennifer M Crowther, Renwick C J Dobson and 2 more

Open access · goldAbstract read
In one paragraph

Article in The Journal of biological chemistry. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Coordinated NADPH oxidase/hydrogen peroxide functions regulate cutaneous sensory axon de- and regeneration.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  10. Antioxidant Therapy in Cancer: Rationale and Progress.Antioxidants (Basel, Switzerland) · 2022
    Review
  11. Prdx1 Interacts with ASK1 upon Exposure to HAntioxidants (Basel, Switzerland) · 2021
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Alexander V PeskinDepartment of Pathology and Biomedical Science, University of Otago Christchurch, Christchurch, New Zealand.
Flavia C MeottiDepartment of Biochemistry, Chemistry Institute, University of Sao Paulo, Sao Paulo, SP, Brazil.
Kelsey M KeanDepartment of Biochemistry and Biophysics, Oregon State University, Corvallis, Oregon, USA.
Christoph GöblDepartment of Pathology and Biomedical Science, University of Otago Christchurch, Christchurch, New Zealand.
Albert Souza PeixotoDepartment of Biochemistry, Chemistry Institute, University of Sao Paulo, Sao Paulo, SP, Brazil.
Paul E PaceDepartment of Pathology and Biomedical Science, University of Otago Christchurch, Christchurch, New Zealand.
Christopher R HorneSchool of Biological Sciences, University of Canterbury, Christchurch, New Zealand.
Sarah G HeathDepartment of Pathology and Biomedical Science, University of Otago Christchurch, Christchurch, New Zealand.
Jennifer M CrowtherSchool of Biological Sciences, University of Canterbury, Christchurch, New Zealand.
Renwick C J DobsonSchool of Biological Sciences, University of Canterbury, Christchurch, New Zealand.
P Andrew KarplusDepartment of Biochemistry and Biophysics, Oregon State University, Corvallis, Oregon, USA. Electronic address: andy.karplus@oregonstate.edu.
Christine C WinterbournDepartment of Pathology and Biomedical Science, University of Otago Christchurch, Christchurch, New Zealand. Electronic address: christine.winterbourn@otago.ac.nz.
University of Otago · NZUniversity of Canterbury · NZOregon State University · USUniversidade de São Paulo · BR

Funding

SEEDING POSTDOCTORAL INNOVATORS IN RESEARCH &EDUCATIONK12GM000678 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DONALD T LYSLE, Kathryn Joanna Reissner · 1999 to 2026
$30.9M
Mechanisms and Regulation of PeroxiredoxinsR01GM119227 · NIGMS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI POOLE, LESLIE B · 2016 to 2019
$1.4M
NIGMS NIH HHS K12 GM000678NIGMS NIH HHS R01 GM119227
6 · The paper itself

Abstract

Peroxiredoxin 2 (Prdx2) is a thiol peroxidase with an active site Cys (C52) that reacts rapidly with H

Indexed as

Amino Acid SequenceCatalytic DomainCrystallography, X-RayCysteineHumansHydrogen PeroxideMutationOxidantsOxidation-ReductionPeroxiredoxinsStructure-Activity RelationshipCysteineHydrogen PeroxideOxidantsPeroxiredoxinsPRDX2 protein, humancrystal structurehydrogen peroxidekineticsperoxiredoxinredox regulationresolving Cys mutants

Identifiers

PMID33667550
PMCPMC8049995
OpenAlexW3134409844

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.